These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 10733345

  • 1. Characteristics of EGFR family-mediated HRG signals in human ovarian cancer.
    Campiglio M, Ali S, Knyazev PG, Ullrich A.
    J Cell Biochem; 1999 Jun 15; 73(4):522-32. PubMed ID: 10733345
    [Abstract] [Full Text] [Related]

  • 2. Distinct characteristics of heregulin signals mediated by HER3 or HER4.
    Weiss FU, Wallasch C, Campiglio M, Issing W, Ullrich A.
    J Cell Physiol; 1997 Nov 15; 173(2):187-95. PubMed ID: 9365520
    [Abstract] [Full Text] [Related]

  • 3. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG, Hosick HL, Ethier SP.
    J Cell Physiol; 2000 Jun 15; 183(3):301-13. PubMed ID: 10797304
    [Abstract] [Full Text] [Related]

  • 4. The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.
    Xu F, Yu Y, Le XF, Boyer C, Mills GB, Bast RC.
    Clin Cancer Res; 1999 Nov 15; 5(11):3653-60. PubMed ID: 10589783
    [Abstract] [Full Text] [Related]

  • 5. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 6. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M, Grijalva R, Yu D.
    Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH.
    EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020
    [Abstract] [Full Text] [Related]

  • 8. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 15; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 9. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
    Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N, Lupu R.
    Oncogene; 1996 Apr 18; 12(8):1679-87. PubMed ID: 8622888
    [Abstract] [Full Text] [Related]

  • 10. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R.
    Cancer J Sci Am; 1997 Apr 18; 3(1):21-30. PubMed ID: 9072304
    [Abstract] [Full Text] [Related]

  • 11. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2000 Jun 18; 183(3):338-46. PubMed ID: 10797308
    [Abstract] [Full Text] [Related]

  • 12. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y, Lin H, Zhu Y, Ma C, Ye J, Luo J.
    J Cell Physiol; 2002 Aug 18; 192(2):225-33. PubMed ID: 12115729
    [Abstract] [Full Text] [Related]

  • 13. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
    Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX.
    Cancer Res; 1996 Mar 15; 56(6):1457-65. PubMed ID: 8640840
    [Abstract] [Full Text] [Related]

  • 14. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D, Kuan CT, Payne J, Kihara A, Murray A, Wang LM, Alimandi M, Pierce JH, Pastan I, Lippman ME.
    Clin Cancer Res; 1998 Apr 15; 4(4):993-1004. PubMed ID: 9563895
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1.
    Landgraf R, Pegram M, Slamon DJ, Eisenberg D.
    Biochemistry; 1998 Mar 03; 37(9):3220-8. PubMed ID: 9485477
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR, Bradley SV, Fuchshuber S, Conover CA.
    Gynecol Oncol; 2004 Sep 03; 94(3):705-12. PubMed ID: 15350362
    [Abstract] [Full Text] [Related]

  • 17. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 19. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
    Takai N, Jain A, Kawamata N, Popoviciu LM, Said JW, Whittaker S, Miyakawa I, Agus DB, Koeffler HP.
    Cancer; 2005 Dec 15; 104(12):2701-8. PubMed ID: 16265675
    [Abstract] [Full Text] [Related]

  • 20. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP.
    Cancer Res; 1997 Mar 01; 57(5):978-87. PubMed ID: 9041204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.